Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Theranostic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchLooking for participantsNCT07608848
What this trial is testing

First-in-human Diagnostic Imaging Profile of the Theranostic Pair [68Ga]Ga-DOTA-STR-17126 and Low Dose [177Lu] Lu-DOTA-STR-17126 in Patients With Advanced or Metastatic Cancer

Who this might be right for
Metastatic Breast CancerMetastatic Prostate CancerGRPR-Targeted Molecular Imaging+5 more
Integrated Haematology and Oncology Network 20
Early research (Phase 1)Looking for participantsNCT07661641
What this trial is testing

[177Lu]Lu-A9-0631 and [225Ac]Ac-A9-0642 With [68Ga]Ga-A9-6217 or [177Lu]Lu-A9-0631 Imaging in GRPR+ Solid Tumors

Who this might be right for
Breast CancerProstate CancerColorectal Cancer+1 more
Alpha-9 Oncology USA Inc. 115
Early research (Phase 1)Looking for participantsNCT07156565
What this trial is testing

Actinium Therapy for Late-stage Aggressive Sarcomas

Who this might be right for
Advanced Soft Tissue Sarcoma
Ratio Therapeutics, Inc. 48
Testing effectiveness (Phase 2)Looking for participantsNCT05655312
What this trial is testing

MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma

Who this might be right for
Recurrent Melanoma (Skin)Metastatic MelanomaMelanoma Stage IV+1 more
Perspective Therapeutics 300
Very early researchActive Not RecruitingNCT03044977
What this trial is testing

Study to Evaluate the Safety of Combining Two Radionuclide Therapies to Treat Mid-gut Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumor, MalignantNeuroendocrine Tumor Gastrointestinal, Hormone-Secreting
David Bushnell 20
Testing effectiveness (Phase 2)Ended earlyNCT05633160
What this trial is testing

64Cu-SAR-BBN and 67CU SAR-BBN for Identification and Treatment of Gastrin Releasing Peptide Receptor (GRPR)-Expressing Metastatic Castrate Resistant Prostate Cancer in Patients Who Are Ineligible for Therapy With 177Lu-PSMA-617 (COMBAT)

Who this might be right for
Prostatic NeoplasmsCastration-Resistant
Clarity Pharmaceuticals Ltd 4
Not applicableLooking for participantsNCT06574373
What this trial is testing

Identification of New Theranostic Biomarkers of Pancreatic Tumor Progression

Who this might be right for
IPMN, Pancreatic
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 3,600
Early research (Phase 1)Active Not RecruitingNCT02088645
What this trial is testing

177Lu-PP-F11N for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer.

Who this might be right for
Thyroid Cancer, MedullaryNeuroendocrine Tumor of the Lung Grade 1 and 2Neuroendocrine Tumor of the Thymus Grade 1 and 2+1 more
University Hospital, Basel, Switzerland 24
Not applicableStudy completedNCT02609737
What this trial is testing

Theranostics of Radiolabeled Somatostatin Antagonists 68Ga-DOTA-JR11 and 177Lu-DOTA-JR11 in Patients With Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumors
Memorial Sloan Kettering Cancer Center 20
Testing effectiveness (Phase 2)Looking for participantsNCT07171905
What this trial is testing

CAT-VHL Exploring the Role of Carbonic Anhydrase IX as Diagnostic and Theranostic Target in Von-Hippel Lindau Disease

Who this might be right for
VHL - Von Hippel-Lindau Syndrome
IRCCS Ospedale San Raffaele 38
Not applicableLooking for participantsNCT07559201
What this trial is testing

Theranostic Applications of Radionuclides in Prostate Cancer

Who this might be right for
Prostate Cancer (Diagnosis)
Guilin Medical University, China 100
Not applicableLooking for participantsNCT06136949
What this trial is testing

The Theranostic Value of STARD3 in Colorectal Cancer: The STAR Study

Who this might be right for
Colorectal Cancer
Centro di Riferimento Oncologico - Aviano 150
Not applicableStudy completedNCT02403102
What this trial is testing

Imageguided Theranostics in Multiple Myeloma

Who this might be right for
CancerMyeloma
Institute of Cancer Research, United Kingdom 61
Not applicableUnknownNCT03220971
What this trial is testing

Lipoprotein and Apolipoproteins With Metabolic Liver Diseases

Who this might be right for
Disorders of Lipoprotein Metabolism and Other Lipidaemias
Chun-Hsiang Wang 440
Testing effectiveness (Phase 2)Looking for participantsNCT04939610
What this trial is testing

177Lu-FAP-2286 in Advanced Solid Tumors

Who this might be right for
Solid Tumor
Novartis Pharmaceuticals 222
Very early researchActive Not RecruitingNCT04665947
What this trial is testing

First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic CancerLocally Advanced Pancreatic Adenocarcinoma
University of California, Davis 30
Not applicableEnded earlyNCT03115138
What this trial is testing

Evaluation of Circulating Tumor DNA as a Theranostic Marker in the Management of Glioblastomas.

Who this might be right for
GlioblastomaMolecular Disease
Centre Hospitalier Universitaire, Amiens 19
Not applicableActive Not RecruitingNCT06834269
What this trial is testing

Transcranial Static Magnetic Stimulation (tSMS) and Potential Theranostic Biomarkers in Amyotrophic Lateral Sclerosis.

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Campus Bio-Medico University 60
Not applicableLooking for participantsNCT07664410
What this trial is testing

Theranostic PET for Target Validation and Tumor Detection

Who this might be right for
Solid Malignancies
University Hospital, Essen 2,000
Not applicableLooking for participantsNCT06815354
What this trial is testing

Comprehensive Assessment of Cancer Theranostic Response

Who this might be right for
Prostate Cancer
AIQ Solutions 32
Next Page